250 related articles for article (PubMed ID: 17119873)
1. Regulation of sarcolemmal transport of substrates in the healthy and diseased heart.
Glatz JF; Bonen A; Ouwens DM; Luiken JJ
Cardiovasc Drugs Ther; 2006 Dec; 20(6):471-6. PubMed ID: 17119873
[TBL] [Abstract][Full Text] [Related]
2. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease.
Schwenk RW; Luiken JJ; Bonen A; Glatz JF
Cardiovasc Res; 2008 Jul; 79(2):249-58. PubMed ID: 18469026
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cardiac long-chain fatty acid and glucose uptake by translocation of substrate transporters.
Luiken JJ; Coort SL; Koonen DP; van der Horst DJ; Bonen A; Zorzano A; Glatz JF
Pflugers Arch; 2004 Apr; 448(1):1-15. PubMed ID: 14872244
[TBL] [Abstract][Full Text] [Related]
4. Differential translocation of the fatty acid transporter, FAT/CD36, and the glucose transporter, GLUT4, coordinates changes in cardiac substrate metabolism during ischemia and reperfusion.
Heather LC; Pates KM; Atherton HJ; Cole MA; Ball DR; Evans RD; Glatz JF; Luiken JJ; Griffin JL; Clarke K
Circ Heart Fail; 2013 Sep; 6(5):1058-66. PubMed ID: 23940308
[TBL] [Abstract][Full Text] [Related]
5. Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters.
Coort SL; Bonen A; van der Vusse GJ; Glatz JF; Luiken JJ
Mol Cell Biochem; 2007 May; 299(1-2):5-18. PubMed ID: 16988889
[TBL] [Abstract][Full Text] [Related]
6. Calcium signaling recruits substrate transporters GLUT4 and CD36 to the sarcolemma without increasing cardiac substrate uptake.
Angin Y; Schwenk RW; Nergiz-Unal R; Hoebers N; Heemskerk JW; Kuijpers MJ; Coumans WA; van Zandvoort MA; Bonen A; Neumann D; Glatz JF; Luiken JJ
Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E225-36. PubMed ID: 24895286
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase-D1 and downstream signaling mechanisms involved in GLUT4 translocation in cardiac muscle.
Simsek Papur O; Glatz JFC; Luiken JJFP
Biochim Biophys Acta Mol Cell Res; 2024 Aug; 1871(6):119748. PubMed ID: 38723678
[TBL] [Abstract][Full Text] [Related]
8. Arsenite modulates cardiac substrate preference by translocation of GLUT4, but not CD36, independent of mitogen-activated protein kinase signaling.
Luiken JJ; Momken I; Habets DD; El Hasnaoui M; Coumans WA; Koonen DP; Glatz JF; Bonen A
Endocrinology; 2006 Nov; 147(11):5205-16. PubMed ID: 17038550
[TBL] [Abstract][Full Text] [Related]
9. Sarcolemmal fatty acid uptake vs. mitochondrial beta-oxidation as target to regress cardiac insulin resistance.
Luiken JJ
Appl Physiol Nutr Metab; 2009 Jun; 34(3):473-80. PubMed ID: 19448717
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the subcellular trafficking of CD36, a major determinant of cardiac fatty acid utilization.
Glatz JF; Nabben M; Heather LC; Bonen A; Luiken JJ
Biochim Biophys Acta; 2016 Oct; 1861(10):1461-71. PubMed ID: 27090938
[TBL] [Abstract][Full Text] [Related]
11. Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis.
Heather LC; Howell NJ; Emmanuel Y; Cole MA; Frenneaux MP; Pagano D; Clarke K
PLoS One; 2011; 6(10):e26326. PubMed ID: 22028857
[TBL] [Abstract][Full Text] [Related]
12. Sarcolemmal fatty acid transport in normal and diseased hearts.
Glatz JF; Bonen A; Luiken JJ
Curr Hypertens Rep; 2007 Dec; 9(6):450-4. PubMed ID: 18367007
[TBL] [Abstract][Full Text] [Related]
13. Exercise and insulin increase muscle fatty acid uptake by recruiting putative fatty acid transporters to the sarcolemma.
Glatz JF; Bonen A; Luiken JJ
Curr Opin Clin Nutr Metab Care; 2002 Jul; 5(4):365-70. PubMed ID: 12107370
[TBL] [Abstract][Full Text] [Related]
14. Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle.
Koonen DP; Glatz JF; Bonen A; Luiken JJ
Biochim Biophys Acta; 2005 Oct; 1736(3):163-80. PubMed ID: 16198626
[TBL] [Abstract][Full Text] [Related]
15. Understanding the distinct subcellular trafficking of CD36 and GLUT4 during the development of myocardial insulin resistance.
Luiken JJFP; Nabben M; Neumann D; Glatz JFC
Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165775. PubMed ID: 32209364
[TBL] [Abstract][Full Text] [Related]
16. Dipyridamole alters cardiac substrate preference by inducing translocation of FAT/CD36, but not that of GLUT4.
Luiken JJ; Coort SL; Willems J; Coumans WA; Bonen A; Glatz JF
Mol Pharmacol; 2004 Mar; 65(3):639-45. PubMed ID: 14978242
[TBL] [Abstract][Full Text] [Related]
17. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.
Bonen A; Parolin ML; Steinberg GR; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ; Dyck DJ
FASEB J; 2004 Jul; 18(10):1144-6. PubMed ID: 15132977
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid transport and transporters in muscle are critically regulated by Akt2.
Jain SS; Luiken JJ; Snook LA; Han XX; Holloway GP; Glatz JF; Bonen A
FEBS Lett; 2015 Sep; 589(19 Pt B):2769-75. PubMed ID: 26296318
[TBL] [Abstract][Full Text] [Related]
19. Exercise training increases sarcolemmal and mitochondrial fatty acid transport proteins in human skeletal muscle.
Talanian JL; Holloway GP; Snook LA; Heigenhauser GJ; Bonen A; Spriet LL
Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E180-8. PubMed ID: 20484014
[TBL] [Abstract][Full Text] [Related]
20. Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes.
Steinbusch LK; Schwenk RW; Ouwens DM; Diamant M; Glatz JF; Luiken JJ
Cell Mol Life Sci; 2011 Aug; 68(15):2525-38. PubMed ID: 21547502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
